TY  - GEN
AU  - Darnaude-Ximénez, Ignacio
AU  - Caballero-Bermejo, Antonio F
AU  - Ruiz-Antorán, Belén
AU  - Aguilar-Pérez, Myriam
AU  - Gomez-Lopez, Alicia
AU  - Sancho-López, Aránzazu
AU  - García-Fadul, Cristian
AU  - Diago-Sempere, Elena
AU  - Valle Falcones, Manuel
AU  - Ussetti-Gil, Piedad
AU  - Avendaño-Solá, Cristina
AU  - PBISA01-Study Group
PY  - 2022
DO  - 10.2196/37275
SN  - 1929-0748
UR  - http://hdl.handle.net/20.500.12105/15983
AB  - Background: Aspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole (ISA) has shown a better safety profile and noninferiority to voriconazole in the treatment of patients with IFD....
LA  - eng
PB  - JMIR Publications
KW  - Alveolar macrophage
KW  - Bronchiole
KW  - Bronchoalveolar lavage
KW  - Bronchoalveolar lavage fluid
KW  - Bronchopulmonary
KW  - Bronchopulmonary level
KW  - Bronchoscopy
KW  - Drug efficacy
KW  - Epithelial lining fluid
KW  - Fungal
KW  - Fungus
KW  - Infection
KW  - Invasive fungal infections
KW  - Isavuconazole
KW  - Lung transplant
KW  - Pharmaceutical
KW  - Pharmacokinetic
KW  - Triazoles
TI  - Bronchopulmonary Penetration of Isavuconazole in Pulmonary Transplant Recipients (PBISA01): Protocol for a Phase IV Clinical Trial With a Single Treatment Arm
TY  - research article
ER  -